HOTH THERAPEUTICS, INC.

Profile

Company Names

HOTH THERAPEUTICS, INC.

Addresses

1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK, NY 10020

1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK, NY 10020

Phone Numbers

646-756-2997
(551) 578-2661

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

NEVADA

Total Amount Raised:

$33,712,120.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-01-03 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
5
2021-03-10 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
4
2021-01-07 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
3
2019-08-16 
$2,037,120.00 
$5,000,000.00 
$2,962,880.00 
Equity 
2
2017-10-25 
$1,000,000.00 
$5,000,000.00 
$4,000,000.00 
 
1
2017-06-30 
$675,000.00 
$675,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
BRIONES 
EXECUTIVE OFFICER
NXT NUTRITIONALS HOLDINGS, INC.   |  PETRO RIVER OIL CORP.   |  HOTH THERAPEUTICS, INC.
ANTHONY 
 
HAYES 
DIRECTOR
FRESENIUS MEDICAL CARE BERKELEY LAKE, LLC   |  NORTH SOUTH HOLDINGS INC.   |  SPHERIX INC   |  FRESENIUS MEDICAL CARE ANDERSON, LLC   |  HOTH THERAPEUTICS, INC.   |  CEI VISION PARTNERS HOLDINGS, LLC   |  LORIENT PET SERVICES, LLC
STEFANIE 
 
JOHNS 
EXECUTIVE OFFICER
HOTH THERAPEUTICS, INC.
ROBB 
 
KNIE 
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
WALLY WORLD MEDIA, INC   |  INVENTERGY, INC.   |  HOTH THERAPEUTICS, INC.
WAYNE 
 
LINSLEY 
DIRECTOR
HOTH THERAPEUTICS, INC.   |  DATCHAT, INC.   |  SILO PHARMA, INC.
VADIM 
 
MATS 
DIRECTOR
WIZARD WORLD, INC.   |  POINT CAPITAL, INC.   |  HOTH THERAPEUTICS, INC.   |  NFT GAMING CO INC.   |  GAXOS.AI INC.
JEFF 
 
PAVELL 
DIRECTOR
HOTH THERAPEUTICS, INC.   |  SILO PHARMA, INC.   |  PATIENT CARE ASSOCIATES, L.L.C.
KENNETH 
 
RICE 
DIRECTOR
HOTH THERAPEUTICS, INC.   |  LIKEMINDS, INC./DE   |  META MATERIALS INC.
DAVID 
 
SARNOFF 
DIRECTOR
HOTH THERAPEUTICS, INC.
DAVID 
B. 
SARNOFF 
DIRECTOR
HOTH THERAPEUTICS, INC.
GRAIG 
 
SPRINGER 
DIRECTOR
HOTH THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-01-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-01-03 
2021-03-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-03-10 
2021-01-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-07 
2019-08-21
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-08-16 
2017-11-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2017-10-25 
2017-07-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
THE BENCHMARK COMPANY, LLC
22982
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037